NASDAQ
Oncotelic Therapeutics, Inc. (OTLC) has a current ratio of 0.07x as of Tuesday, May 26, 2026. This represents a 222.34% increase compared to its 12-month average of 0.02x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.